经口腔前庭入路腔镜甲状腺切除术十年:为何被放弃
该研究回顾2015至2025年2848例甲状腺手术中的650例微创或经皮干预,分析术式使用趋势与并发症。经口腔前庭入路腔镜甲状腺切除术(TOETVA)使用快速下降并实际停止,热消融成为良性结节和部分甲状腺微小乳头状癌的主导微创策略,需要肿瘤学保证时则转向微创视频辅助甲状腺切除术(MIVAT)。
要点
- TOETVA使用快速下降并实际停止,热消融与MIVAT分别承接低风险与需肿瘤学保证的病例。
- 从TOETVA/MIVAT计划转为消融的比例由19.2%升至54.3%,手术年份较晚独立倾向消融。
- TOETVA有入路相关并发症、更高的神经监测失败率和最高的复合并发症负担。
核心结论
- 在高容量内分泌外科项目中,TOETVA被逐步边缘化并实际停止,由消融和MIVAT替代。
研究设计与样本
- 回顾性分析2015至2025年2848例甲状腺手术中的650例微创或经皮干预。
主要发现
- TOETVA使用快速下降,MIVAT和开放手术保持稳定,消融成为良性结节和部分甲状腺微小乳头状癌的主导微创策略。
- 从TOETVA/MIVAT计划转为消融的比例从19.2%升至54.3%,手术年份较晚独立倾向消融。
- 分子学阴性的良性结节与消融关联最强,分子学可疑结节优先转向MIVAT。
- 消融的并发症发生率最低且甲状腺功能保留最好。
- TOETVA有入路相关并发症、更高的神经监测失败率和最高的复合并发症负担。
临床怎么用
- 对细胞学/分子学低风险结节可优先考虑热消融而非TOETVA。
- 需要肿瘤学保证时选择MIVAT而非TOETVA。
- TOETVA应权衡其入路相关并发症和神经监测失败风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transoral endoscopic thyroidectomy vestibular approach (TOETVA) was introduced in our program as a remote-access, "scarless" alternative to open thyroidectomy to meet cosmetic demand. With increasing experience and the availability of outpatient technologies, its role shifted. This study summarizes a decade of practice, showing how the transoral endoscopic thyroidectomy vestibular approach was progressively de-emphasized and discontinued, and identifying clinical and technical factors driving case allocation toward percutaneous thermal ablation or minimally invasive video-assisted thyroidectomy. METHODS: All thyroid procedures performed from 2015 to 2025 were reviewed. Among 2,848 operations, 650 minimally invasive or percutaneous interventions (transoral endoscopic thyroidectomy vestibular approach, minimally invasive video-assisted thyroidectomy, thermal ablation, and open surgery) were analyzed. Primary outcomes were temporal trends in modality use, migration from an initial endoscopic plan to ablation, and approach-specific complications. Secondary endpoints included neuromonitoring performance, long-term levothyroxine requirement, and predictors of selecting ablation or minimally invasive video-assisted thyroidectomy over the transoral endoscopic thyroidectomy vestibular approach. RESULTS: Transoral endoscopic thyroidectomy vestibular approach use declined rapidly, whereas minimally invasive video-assisted thyroidectomy and open surgery remained stable, and ablation became the dominant minimally invasive strategy for benign nodules and selected papillary microcarcinomas. Conversion from transoral endoscopic thyroidectomy vestibular approach/minimally invasive video-assisted thyroidectomy proposals to ablation increased from 19.2% to 54.3%, and the later surgical year independently favored ablation. Benign nodules with negative molecular results showed the strongest association with ablation, whereas molecularly suspicious nodules were preferentially directed to minimally invasive video-assisted thyroidectomy. Ablation had the lowest morbidity and best preservation of thyroid function. The transoral endoscopic thyroidectomy vestibular approach incurred access-specific complications, higher neuromonitoring failures, and the greatest composite complication burden. CONCLUSION: Within a high-volume endocrine surgery program offering all available approaches, the transoral endoscopic thyroidectomy vestibular approach was progressively marginalized and effectively discontinued, supplanted by ablation for cytologically/molecularly low-risk nodules and by minimally invasive video-assisted thyroidectomy when oncologic assurance was required.
引用
- Zhang D, Brucchi F, Colombo C, et al. Ten years after transoral endoscopic thyroidectomy vestibular approach (TOETVA): Why did we abandon the transoral route? Surgery. 2026. PMID: 42208475. doi:10.1016/j.surg.2026.110292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。